SCHEMBL1506470

SCHEMBL1506470

COC(=O)c1cc2c(cc1I)CCC2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.38
CFTR P13569 1/20 0.36
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 2/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HSD17B1 P14061 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA3 P34903 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26984755 0.81 HSD17B1 (0.40) PBRM1CFTRKDM4EL3MBTL1MAPT
SCHEMBL3971100 0.81 GAA (0.45) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL1506543 0.81 KDM4E (0.50) PBRM1CFTRKDM4EMAPTGLA
SCHEMBL25227132 0.78 KDM4E (0.50) PBRM1CFTRKDM4EMAPTGLA
SCHEMBL4817740 0.78 GAA (0.45) KDM4EGAAALDH1A1HPGDHSD17B10
SCHEMBL15690534 0.78 HSD17B1 (0.40) PBRM1CFTRKDM4EL3MBTL1MAPT
SCHEMBL14666358 0.75 CFTR (0.53) CFTRKDM4EL3MBTL1MAPTGLA
SCHEMBL26984422 0.74 CYP1A2 (0.44) KDM4EL3MBTL1RAB9ATDP1ALDH1A1
SCHEMBL2304117 0.73 KDM4E (0.44) PBRM1KDM4EALDH1A1HPGDCASP1
SCHEMBL1506638 0.73 MAOB (0.38) KDM4EMAPTGLAGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971595-B1 CETP INHIBITORS MERCK SHARP & DOHME (US) 2013-10-16 EP disclosed
US-7910592-B2 CETP inhibitors MERCK SHARP & DOHME CORP. (US) 2011-03-22 US disclosed
US-20090042892-A1 Cetp Inhibitors MERCK SHARP & DOHME LLC 2009-02-12 US disclosed
EP-1971595-A2 CETP INHIBITORS Merck & Co., Inc. (US) 2008-09-24 EP disclosed
WO-2007081569-A2 CETP INHIBITORS MERCK & CO., INC. (US) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042892-A1 Cetp Inhibitors CETP, APOB, MTTP PBRM1 2535/4885CFTR 2532/4885KDM4E 2213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.